1. Home
  2. SCCO vs SNY Comparison

SCCO vs SNY Comparison

Compare SCCO & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Copper Corporation

SCCO

Southern Copper Corporation

HOLD

Current Price

$188.05

Market Cap

121.3B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$47.39

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCCO
SNY
Founded
1952
1994
Country
United States
France
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.3B
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCCO
SNY
Price
$188.05
$47.39
Analyst Decision
Sell
Buy
Analyst Count
10
6
Target Price
$124.28
$61.50
AVG Volume (30 Days)
1.9M
2.8M
Earning Date
02-11-2026
01-29-2026
Dividend Yield
1.94%
3.39%
EPS Growth
25.54
105.93
EPS
4.67
8.67
Revenue
$12,334,600,000.00
$53,890,648,839.00
Revenue This Year
$15.74
$1.73
Revenue Next Year
$6.81
$6.49
P/E Ratio
$39.43
$5.44
Revenue Growth
12.70
N/A
52 Week Low
$72.75
$44.62
52 Week High
$191.22
$60.12

Technical Indicators

Market Signals
Indicator
SCCO
SNY
Relative Strength Index (RSI) 71.64 47.02
Support Level $174.45 $46.10
Resistance Level $191.22 $48.17
Average True Range (ATR) 6.86 0.80
MACD 1.03 -0.02
Stochastic Oscillator 88.22 51.10

Price Performance

Historical Comparison
SCCO
SNY

About SCCO Southern Copper Corporation

Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: